Package Insert: Information for the Patient

Alopurinol Tarbis 300 mg Tablets EFG

Read this package insert carefully before starting to take this medication, as it contains important information for you.

• Keep this package insert, as you may need to refer to it again.
• If you have any questions, consult your doctor or pharmacist.
• This medication has been prescribed only for you, and you should not give it to others even if they have the same symptoms as you, as it may harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this package insert. See section 4.

This medication contains the active ingredient alopurinol.

This medication works by reducing the speed of certain chemical reactions in the body to decrease the level of uric acid in the blood and urine.

High levels of uric acid can cause:

• Gout
• Formation of kidney stones or certain types of kidney problems

In gout, uric acid accumulates in joints and tendons in the form of crystals. These crystals cause an inflammatory reaction. The inflammation makes the skin around certain joints swell, become sensitive, and hurt only when touched lightly. It can also be observed that intense pain occurs when moving the joint.

Alopurinol Tarbis is used in adults:

• To reduce uric acid levels when diet is not sufficient
• For the treatment and prevention of the aforementioned complications, in which the body produces too much uric acid.

Do not take Alopurinol Tarbis:

• If you are allergic to allopurinol or any of the other components of this medication (listed in section 6)

Warnings and precautions

Inform your doctor or pharmacist before taking this medication if:

• You have liver and kidney problems. Your doctor may administer a lower dose or ask you to take it less frequently. They will also monitor you more closely.
• You are currently experiencing a gout attack. Your doctor may also consider prescribing an appropriate analgesic or another gout medication (colchicine) during the first 4 weeks of treatment.
• You have thyroid problems.
• You have Chinese Han, Thai, or Korean ancestry.

Be especially careful with Alopurinol Tarbis:

Severe skin reactions(Hypersensitivity syndrome, Stevens-Johnson syndrome, Toxic Epidermal Necrolysis) have been reported with the use of allopurinol. These may initially appear as red patches, bullet-shaped or circular (often with blisters in the middle) on the trunk of the body. The rash may also include ulcers in the mouth, throat, nose, genitals, and conjunctivitis (inflammation and redness of the eyes). These potentially fatal skin reactions are usually preceded by symptoms similar to the flu (fever, headache, and body aches). The rash may progress to the formation of blisters and generalized peeling of the skin. If you develop a skin rash or these symptoms on the skin,stop taking allopurinol and consult your doctor immediately.

If you have experienced a severe skin reaction during treatment with allopurinol, you should not be treated with allopurinol again.

These severe skin reactions may be more common in people of Chinese Han, Thai, or Korean origin. Additionally, chronic renal insufficiency may increase the risk in these patients.

If you have cancer or Lesch-Nyhan syndromeThe amount of uric acid in urine may increase. To prevent this, make sure to drink enough water to dilute your urine.

In case you have kidney stonesThe stones will become smaller and may enter your urinary tract, which could cause problems. The amount of urine you produce should be at least 2 liters per day to reduce the risk of kidney stone formation. Make sure to drink enough water.

Children and adolescents

Use in children is rarely indicated, except for some types of cancer (especially leukemia) and certain enzymatic disorders such as Lesch-Nyhan syndrome.

Other medications and Alopurinol Tarbis

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This includes over-the-counter medications, including herbal medications. This is because allopurinol may affect the functioning of some medications. Some other medications may also affect the functioning of Alopurinol Tarbis.

Inform your doctor if you are taking any of the following medications:

Taking Alopurinol Tarbis with food, drinks, and alcohol

Avoid foods high in purines, such as organ meats like liver, kidneys, brain, heart, and tongue, as well as concentrated meat and alcohol, especially beer.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.

Do not take this medication if you are pregnant unless your doctor recommends it.

Alopurinol is not recommended during breastfeeding. Your doctor will decide whether to discontinue breastfeeding or discontinue/discontinue treatment with allopurinol.

Driving and operating machinery

You may feel drowsy, dizzy, or have coordination problems. If this occurs, do not drive or operate any tools or machinery.

Alopurinol Tarbis contains lactose

If your doctor has told you that you have a certain sugar intolerance, consult with them before taking this medication.

Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.

Adults

The recommended dose is 300 mg of allopurinol per day. Generally, you will start with a low dose to reduce the risk of side effects. If you need a lower dose, other doses of this medication are available.

Your doctor may increase the dose to 600 mg to 800 mg of allopurinol, if necessary.

The maximum daily dose is 800 mg of allopurinol.

The tablets should be taken once a day after a meal, especially in patients with a sensitive stomach. To avoid side effects, do not take more than 300 mg of allopurinol in a single dose. If a daily dose of more than 300 mg of allopurinol is indicated or if gastrointestinal side effects (nausea, vomiting, diarrhea) occur, the dose may be divided into several doses throughout the day.

Your doctor will indicate the correct dose.

Make sure to drink enough water while taking this medication.

Older patients

If you are an older person, your doctor may prescribe a lower dose or advise you to take the tablets at longer intervals.

Patients with kidney or liver problems

Alopurinol Tarbis 300 mg is not suitable if you have severely reduced liver or kidney function due to the high content of allopurinol. Other doses of this medication may be more suitable; consult your doctor or pharmacist.

If you undergo dialysis two or three times a week, your doctor may prescribe a dose of 300 or 400 mg that you should take immediately after dialysis.

Your doctor will generally start with a low dose of allopurinol (for example, 100 mg/day), to reduce the risk of possible side effects. Your dose will be increased if necessary.

Use in children and adolescents under 15 years

Alopurinol Tarbis 300 mg is not suitable for children due to the high content of allopurinol. Other doses of this medication may be more suitable; consult your doctor or pharmacist.

Administration method

Oral route.

Take the tablet after a meal and swallow it with a glass of water, approximately at the same time every day.

The groove is only for breaking and facilitating swallowing, but not for dividing into equal doses.

Treatment duration

The duration of treatment with this medication depends on the underlying disease. Please take allopurinol regularly and for the time your doctor has indicated.

Continuous monitoring by your doctor is necessary. Your doctor should check your uric acid levels repeatedly and regularly through blood tests. At the same time, possible side effects should be observed, and you should speak with your doctor or pharmacist if you consider that the effect of this medication is too strong or too weak.

If you take more Alopurinol Tarbis than you should

If you take more allopurinol than you should, contact your doctor or go to the hospital immediately. Bring the packaging of this medication with you. Signs of overdose may include nausea, vomiting, diarrhea, and dizziness.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

If you forgot to take Alopurinol Tarbis

If you forget to take a dose, do not take a double dose to compensate for the missed doses.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

Like all medicines, this medicine can have side effects, although not everyone will experience them.

If you have any of the following side effects, stop taking this medicine immediately and inform your doctor.

Hyper-sensitivity (allergic reactions)

Rare(may affect 1 in 1,000 people)

• Fever and chills, headache, muscle pains (symptoms similar to the flu) and general discomfort. Any change in the skin, for example; mouth ulcers, throat, nose, genital, or conjunctivitis (red and swollen eyes), blisters or generalized peeling.
• Severe allergic reactions that include fever, skin rash, general pain, and abnormalities in blood and liver function tests (may be signs of a multi-organ sensitivity disorder).

Very rare(may affect up to 1 in 10,000 people)

• Severe and potentially fatal skin reaction (hypersensitivity reactions, Stevens-Johnson syndrome, and toxic epidermal necrolysis) (see section 2).
• Severe allergic reaction that causes swelling of the face or throat.
• Severe and potentially fatal allergic reaction.

If you have gout, you may experience a gout attack at the start of treatment with allopurinol.

It is more common to experience side effects if you have kidney or liver problems or if you are taking ampicillin or amoxicillin at the same time.

Other side effects

Common(may affect up to 1 in 10 people)

• Skin reactions (eczema)
• Elevated levels of thyroid-stimulating hormone in the blood

Uncommon(may affect 1 in 100 people)

• Diarrhea
• Feeling unwell (nausea) or vomiting
• Abnormal results in liver function tests

Rare(may affect up to 1 in 1,000 people)

• Liver problems, such as inflammation of the liver

Very rare(may affect 1 in 10,000 people)

• May affect the lymph nodes
• Gastrointestinal bleeding
• Easy bruising, or you may develop sore throat or other signs of infection. These effects usually occur in people with liver or kidney problems. Inform your doctor as soon as possible.
• General weakness (asthenia), numbness, instability in the feet, sensation of inability to move muscles (paralysis) or loss of consciousness
• General feeling of discomfort or weakness
• Furunculosis (ulcerative inflammation of the skin)
• Chest pain (angina), high blood pressure, or slow pulse
• High levels of urea in the blood (uremia)
• Blood in the urine (hematuria)
• Vomiting blood (hematemesis)
• Change in normal bowel habits or excessive fat in stools (steatorrhea)
• Accumulation of fluid leading to swelling, particularly in the face (Quincke's edema)
• Enlargement of the breasts in men
• Sensation of tingling, prickling, stinging, or burning in the skin (paresthesia)
• Inflammation of the mucous membrane of the mouth
• High levels of cholesterol in the blood (hyperlipidemia)
• Change in taste
• Hair loss or discoloration
• Infertility or erectile dysfunction
• Headache, dizziness, drowsiness, or visual disturbances
• Lack of voluntary coordination of muscle movements (ataxia), muscle pain
• Depression
• Cataracts
• Abnormal glucose metabolism (diabetes)

Unknown frequency(cannot be estimated from available data): aseptic meningitis (inflammation of the membranes surrounding the brain and spinal cord): symptoms include stiffness in the neck, headache, nausea, fever, or mental confusion. Seek medical attention immediately if this occurs.

Reporting of side effects

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es.

By reporting side effects, you can contribute to providing more information on the safety of this medicine

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging and on the blister pack after 'CAD'. The expiration date is the last day of the month indicated.

Store below 25°C

Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and unused medications at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and unused medications. By doing so, you will help protect the environment.

Composition of Alopurinol Tarbis

The active ingredient is alopurinol.

Each tablet contains 300 mg of alopurinol.

The other excipients are:

Lactose monohydrate, cornstarch, crospovidone (Type A and B), povidone (K 30) and magnesium stearate.

Appearance of the product and contents of the packaging

Round tablets of 11.10 mm x 5.4 mm, white to off-white in color, engraved with a “U” and a “6” on one side and a scored line with an “H” on the other side.

The score is only for breaking and facilitating swallowing, but not for dividing into equal doses.

Blister packs containing 25, 30, 50, 90, 100 and 500 tablets.

Only some packaging sizes may be commercially available.

Marketing Authorization Holder

Tarbis Farma S.L.

Gran Vía Carlos III, 94

08028 Barcelona

Spain

Responsible for manufacturing

Amarox Pharma B.V.

Rouboslaan 32

Voorschoten, 2252TR

Netherlands

This medicine is authorized in the member states of the European Economic Area with the following names:

Germany:Allopurinol Amarox 300 mg Tabletten

Spain:Alopurinol Tarbis 300 mg comprimidos EFG

Netherlands:Allopurinol Amarox 300 mg tabletten

Last review date of this leaflet: September 2023

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/